Brief: Elicera Therapeutics Enters Collaboration With Spanish Research Institution
Oct 18 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* ELICERA THERAPEUTICS ENTERS FIRST INTERNATIONAL
COLLABORATION
INVOLVING THE ITANK PLATFORM WITH A SPANISH RESEARCH INSTITUTION
* AGREEMENT DOES NOT GRANT JCLRI ANY INTELLECTUAL PROPERTY
RIGHTS
TO ITANK-PLATFORM, AND ANY PATENTABLE INVENTIONS ARISING FROM
PROJECT SHALL BECOME JOINT PROPERTY OF ELICERA AND JCLRI
Source text for Eikon: ID:nWkr1Zh69q
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application